Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

Clinical trial NCT05831098 · COMPLETED

Trial details

NCT number: NCT05831098
Sponsor: MedMira Laboratories Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Syphilis Infection Syphilis Early Syphilis, Symptomatic

Start date: 2023-05-12
Primary completion: 2024-12-06
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.